Financials

News Ideas Discussions Technicals Seasonals

IXC fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to INVEX THERAPEUTICS LTD operating, investing, and financing activities

IXC free cash flow for H1 25 is -241.61 k AUD. For 2024, IXC free cash flow was -2.44 M AUD and operating cash flow was -2.44 M AUD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: AUD

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—